STAAR Surgical Company
STAA
$18.84
$0.452.45%
NASDAQ
| 01/02/2026 | 09/26/2025 | 06/27/2025 | 03/28/2025 | 12/27/2024 | |
|---|---|---|---|---|---|
| Net Income | -298.10% | -542.54% | -673.47% | -564.64% | -194.66% |
| Total Depreciation and Amortization | 20.72% | 51.66% | 58.90% | 52.47% | 34.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.60% | 55.06% | 27.00% | 56.35% | 31.23% |
| Change in Net Operating Assets | -82.14% | 156.07% | 219.97% | 137.18% | 78.05% |
| Cash from Operations | -317.68% | -163.07% | -176.55% | -128.26% | 7.75% |
| Capital Expenditure | 75.12% | 52.46% | 35.83% | 4.05% | -28.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 245.60% | 1,533.02% | -71.48% | -120.17% | -138.71% |
| Cash from Investing | 178.25% | 367.08% | -88.47% | -149.69% | -179.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 74.55% | 49.39% | 22.36% | -5.03% | -2.48% |
| Issuance of Common Stock | -53.10% | -56.27% | -84.39% | -83.09% | -23.56% |
| Repurchase of Common Stock | -430.30% | -467.36% | -293.90% | -5.55% | 28.23% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -179.58% | -174.42% | -134.06% | -94.39% | -22.81% |
| Foreign Exchange rate Adjustments | 229.34% | -71.47% | 277.92% | 115.03% | -650.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 123.13% | -66.77% | -126.15% | -137.98% | -140.26% |